Validating the NIH LDL-C equation for provincial implementation in Alberta

被引:0
|
作者
Higgins, V. [1 ,2 ]
Garcia, L. [2 ]
Gifford, J. L. [3 ,4 ]
Volodko, N. [1 ,2 ]
Beriault, D. R. [5 ,6 ]
Parker, M. L. [1 ,2 ]
Estey, M. P. [1 ,2 ]
Proctor, D. T. [1 ,2 ]
Ismail, O. Z. [1 ,2 ]
机构
[1] DynaLIFE Med Labs, Edmonton, AB, Canada
[2] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada
[3] DynaLIFE Med Labs, Calgary, AB, Canada
[4] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada
[5] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[6] St Michaels Hosp, Dept Lab Med & Pathobiol, Toronto, ON, Canada
关键词
LDL-C; Triglycerides; Lipid panel; Cardiovascular disease; DENSITY-LIPOPROTEIN CHOLESTEROL; SOCIETY;
D O I
10.1016/j.clinbiochem.2023.110678
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: LDL-C, a cardiovascular disease risk assessment biomarker, is commonly calculated using the Friedewald equation. The NIH equation overcomes several limitations of the Friedewald equation. Consistent with the Canadian Society of Clinical Chemists (CSCC) lipid reporting recommendations, we assessed the NIH LDL-C equation in Alberta prior to its provincial implementation.Methods: 1-year (01/01/2021-12/31/2021) of lipid results (n = 1,486,584 after data cleaning) were obtained from five analytical instrument groups used across Alberta. Analyses were performed on all data and after separating by age, analytical instrument group, and fasting status. The correlation between Friedewald- and NIHcalculated LDL-C and between Friedewald- and NIH-calculated LDL-C difference and each lipid parameter, was determined. The frequency of unreportable/inaccurate LDL-C results was compared between the two equations. The concordance between the two equations and with non-HDL-C was determined at LDL-C thresholds. Lastly, LDL-C calculated by Friedewald, NIH, and Martin-Hopkins equations was compared to density-gradient ultracentrifugation. Results: Friedewald- and NIH-calculated LDL-C exhibit the strongest correlation when triglycerides <= 4.52 mmol/ L. The difference between Friedewald- and NIH-calculated LDL-C increases with decreasing LDL-C concentration. The NIH equation yields fewer inaccurate results (0.35 % vs. 22.0 %). The percent agreement between equations was > 96 % at all LDL-C thresholds, suggesting most patients will not require treatment changes. NIH-calculated LDL-C exhibited better agreement with non-HDL-C when triglycerides <= 9.04 mmol/L and better correlated with LDL-C measured by ultracentrifugation (r(2) = 0.926 vs. 0.775 (Friedewald) and 0.863 (Martin-Hopkins)). Results were consistent across age, analytical instrument group, and fasting status.Conclusions: Our findings demonstrate the benefits of implementing the NIH equation across Alberta.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Validating the NIH LDL-C equation in a specialized lipid cohort: Does it add up?
    Higgins, Victoria
    Leiter, Lawrence A.
    Delaney, Sarah R.
    Beriault, Daniel R.
    CLINICAL BIOCHEMISTRY, 2022, 99 : 60 - 68
  • [2] Assessment of LDL-C Calculation Using the Newly Adopted NIH LDL-C Equation in a Pediatric Population
    Chan, Ka Keung
    Dickerson, Jane A.
    CLINICAL CHEMISTRY, 2022, 68 (10) : 1338 - 1339
  • [3] The Sampson-NIH Equation Is the Preferred Calculation Method for LDL-C
    Sampson, Maureen
    Wolska, Anna
    Meeusen, Jeff W.
    Otvos, James
    Remaley, Alan T.
    CLINICAL CHEMISTRY, 2023, : 399 - 402
  • [4] Evaluate LDL-C using NIH equation 2, Friedewald equation, and direct homogeneous measurement
    Faught, R.
    Hagrass, H.
    CLINICAL CHEMISTRY, 2024, 70 : I82 - I82
  • [5] An improved method for estimating low LDL-C based on the enhanced Sampson-NIH equation
    Tatiana C. Coverdell
    Maureen Sampson
    Rafael Zubirán
    Anna Wolska
    Leslie J. Donato
    Jeff W. Meeusen
    Allan S. Jaffe
    Alan T. Remaley
    Lipids in Health and Disease, 23
  • [6] An improved method for estimating low LDL-C based on the enhanced Sampson-NIH equation
    Coverdell, Tatiana C.
    Sampson, Maureen
    Zubiran, Rafael
    Wolska, Anna
    Donato, Leslie J.
    Meeusen, Jeff W.
    Jaffe, Allan S.
    Remaley, Alan T.
    LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [7] A modified Sampson LDL-C equation to improve concordance with the reference method at low levels of LDL-C
    Sampson, M.
    Meeusen, J. W.
    Donato, L. J.
    Jaffe, A. S.
    Remaley, A. T.
    CLINICAL CHEMISTRY, 2024, 70 : I88 - I88
  • [8] Performance of the enhanced Sampson-NIH equation for VLDL-C and LDL-C in a population with familial combined hyperlipidemia
    Zubiran, Rafael
    Vargas-Vazquez, Arsenio
    Olvera, Fabiola Del Razo
    Cruz-Bautista, Ivette
    Martagon-Rosado, Alexandro
    Sampson, Maureen
    Remaley, Alan T.
    Aguilar-Salinas, Carlos A.
    ATHEROSCLEROSIS, 2023, 386
  • [9] COMPARISON OF SIGMA DIRECT LDL-C AND THE CALCULATED LDL-C
    HOHNADEL, DC
    VANVESSEM, T
    ROWLAND, S
    DSOUZA, J
    CLINICAL CHEMISTRY, 1995, 41 (06) : S198 - S198
  • [10] Is the 2020 Sampson equation the best formula for LDL-C estimation?
    Piani, Federica
    Cicero, Arrigo F. G.
    Borghi, Claudio
    D'Addato, Sergio
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 83 : 99 - 101